Mutagen-specific mutation signature determines global microRNA binding. by Eyal Greenberg, Gideon Rechavi, Ninette Amariglio, Oz Solomon, Jacob Schachter, Gal Markel, Eran Eyal

Get full text

Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience by Nethanel Asher, Noa Israeli-Weller, Ronnie Shapira-Frommer, Guy Ben-Betzalel, Jacob Schachter, Tomer Meirson, Gal Markel

Get full text

Better Late Than Never: The Impact of Steroidal Treatment on the Outcome of Melanoma Patients Treated with Immunotherapy by Neta Bar-Hai, Guy Ben-Betzalel, Ronen Stoff, Shirly Grynberg, Jacob Schachter, Ronnie Shapira-Frommer, Nethanel Asher

Get full text

Real world evidence of Lenvatinib + anti PD-1 as an advanced line for metastatic melanoma by Ronen Stoff, Nethanel Asher, Shachar Laks, Yael Steinberg, Jacob Schachter, Ronnie Shapira-Frommer, Shirly Grynberg, Guy Ben-Betzalel

Get full text

Regulation of CEACAM1 Protein Expression by the Transcription Factor ETS-1 in BRAF-Mutant Human Metastatic Melanoma Cells by Karin Kfir-Elirachman, Rona Ortenberg, Bella Vizel, Michal J Besser, Iris Barshack, Jacob Schachter, Yael Nemlich, Gal Markel

Get full text

Radiotherapy may augment response to immunotherapy in metastatic uveal melanoma patients by Shirly Grynberg, Ronen Stoff, Nethanel Asher, Ronnie Shapira-Frommer, Jacob Schachter, Ory Haisraely, Yaacov Lawrence, Guy Ben-Betzalel

Get full text

Efficacy and toxicity of Ipilimumab-Nivolumab combination therapy in elderly metastatic melanoma patients by Ronen Stoff, Shirly Grynberg, Nethanel Asher, Shachar Laks, Yael Steinberg, Jacob Schachter, Ronnie Shapira-Frommer, Guy Ben-Betzalel

Get full text

Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex by Eyal Greenberg, Steven Hajdu, Yael Nemlich, Ronit Cohen, Orit Itzhaki, Jasmine Jacob-Hirsch, Michal J. Besser, Jacob Schachter, Gal Markel

Get full text

Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy by Sharon Yunger, Assaf Bar El, Li-at Zeltzer, Eddie Fridman, Gil Raviv, Menachem Laufer, Jacob Schachter, Gal Markel, Orit Itzhaki, Michal J Besser

Get full text

Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma by Nethanel Asher, Guy Ben-Betzalel, Shaked Lev-Ari, Ronnie Shapira-Frommer, Yael Steinberg-Silman, Neta Gochman, Jacob Schachter, Tomer Meirson, Gal Markel

Get full text

Development of allogeneic NK cell adoptive transfer therapy in metastatic melanoma patients: in vitro preclinical optimization studies. by Michal J Besser, Tsipi Shoham, Orit Harari-Steinberg, Naama Zabari, Rona Ortenberg, Arkadi Yakirevitch, Arnon Nagler, Ron Loewenthal, Jacob Schachter, Gal Markel

Get full text

Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation by Sivan Seliktar-Ofir, Sivan Seliktar-Ofir, Efrat Merhavi-Shoham, Orit Itzhaki, Sharon Yunger, Gal Markel, Gal Markel, Jacob Schachter, Michal J. Besser, Michal J. Besser

Get full text

Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy by Ronnie Shapira-Frommer, Elad Jacoby, Orit Itzhaki, Abraham Nissani, Gal Markel, Jacob Schachter, Shaked Lev-Ari, Tomer Meirson, Nethanel Asher, Guy Ben-Betzalel, Michal J. Besser

Get full text

Immune co-culture cell microarray – a feasible tool for high-throughput functional investigation of lymphocyte–cancer interactions by Erez Nissim Baruch, Rona Ortenberg, Camila Avivi, Liat Anafi, Daniela Dick-Necula, Chani Stossel, Yonatan Moshkovits, Orit Itzhaki, Michal Judith Besser, Jacob Schachter, Iris Barshack, Gal Markel

Get full text

Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanoma. by Orit Itzhaki, Eyal Greenberg, Bruria Shalmon, Adva Kubi, Avraham J Treves, Ronnie Shapira-Frommer, Camilla Avivi, Rona Ortenberg, Eytan Ben-Ami, Jacob Schachter, Michal J Besser, Gal Markel

Get full text

Regulation of cancer aggressive features in melanoma cells by microRNAs. by Eyal Greenberg, Liat Hershkovitz, Orit Itzhaki, Steven Hajdu, Yael Nemlich, Rona Ortenberg, Nir Gefen, Liat Edry, Shira Modai, Yona Keisari, Michal J Besser, Jacob Schachter, Noam Shomron, Gal Markel

Get full text

Genetic Modification of Tumor-Infiltrating Lymphocytes via Retroviral Transduction by Hadas Weinstein-Marom, Hadas Weinstein-Marom, Hadas Weinstein-Marom, Hadas Weinstein-Marom, Gideon Gross, Gideon Gross, Michal Levi, Hadar Brayer, Jacob Schachter, Orit Itzhaki, Michal J. Besser, Michal J. Besser

Get full text

Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia by Meir Rozenbaum, Meir Rozenbaum, Meir Rozenbaum, Amilia Meir, Yarden Aharony, Orit Itzhaki, Jacob Schachter, Ilan Bank, Elad Jacoby, Elad Jacoby, Elad Jacoby, Michal J. Besser, Michal J. Besser, Michal J. Besser

Get full text

CEACAM1 Promotes Melanoma Cell Growth through Sox-2 by Rona Ortenberg, Gilli Galore-Haskel, Ilanit Greenberg, Bella Zamlin, Sivan Sapoznik, Eyal Greenberg, Iris Barshack, Camila Avivi, Yulia Feiler, Israel Zan-Bar, Michal J. Besser, Ester Azizi, Friedman Eitan, Jacob Schachter, Gal Markel

Get full text

Molecular and Functional Signatures Associated with CAR T Cell Exhaustion and Impaired Clinical Response in Patients with B Cell Malignancies by Katia Beider, Orit Itzhaki, Jacob Schachter, Ania Hava Grushchenko-Polaq, Valeria Voevoda-Dimenshtein, Evgenia Rosenberg, Olga Ostrovsky, Olivia Devillers, Ronnie Shapira Frommer, Li-at Zeltzer, Amos Toren, Elad Jacoby, Avichai Shimoni, Abraham Avigdor, Arnon Nagler, Michal J. Besser

Get full text